01—Abstract
Summary
Summary of the 8-K filed December 4, 2025. Cited figures are marked; the original filing is the authoritative source.
Stryker (NYSE: SYK) announced on December 4, 2025 a leadership succession that elevates Spencer Stiles to President and Chief Operating Officer, effective January 1, 2026.
Stiles, a 27-year company veteran who has led Orthopaedics since 2019, will oversee the global businesses, strategy, and mergers and acquisitions, positioning him as a central figure in the company's growth agenda. The move is framed by CEO Kevin Lobo as a way to sustain high growth and leverage the breadth of Stryker's MedSurg, Neurotechnology, and Orthopaedics portfolio. To backfill the Orthopaedics role, Dylan Crotty, currently President of Instruments and also a 27-year Stryker veteran, will become Group President, Orthopaedics, effective the same date.
The filing discloses a compensation step-up for both executives: Stiles's base salary rises to $1,000,000a with a 100% bonus target, and Crotty's rises to $700,000 with an 85% bonus target. The Compensation and Human Capital Committee will also be asked to approve February 2026 long-term incentive grants with aggregate target values of roughly $6 million for Stiles and $3 million for Crotty, split 40% stock options and 60% performance stock units. For investors, this is primarily a planned internal succession rather than a strategic shift or a financial event, and the filing contains no disclosed impact on guidance or financial results.
The key signals are continuity, since both successors are long-tenured insiders, and the enhanced incentive structure, which ties a larger share of executive pay to multi-year performance. The stated M&A responsibility for the new COO is worth monitoring, as it may signal a greater role for acquisitions in Stryker's future capital allocation.
02—Key points
Key Highlights
- Spencer Stiles appointed President and Chief Operating Officer effective January 1, 2026, overseeing global businesses, strategy, and M&A
- Dylan Crotty promoted from President, Instruments to Group President, Orthopaedics, succeeding Stiles, effective January 1, 2026
- Stiles's base salary increases to $1,000,000 with a 100% target bonus; Crotty's base rises to $700,000 with an 85% target bonus
- Proposed February 2026 LTIP awards: approximately $6M for Stiles and $3M for Crotty, each 40% stock options and 60% performance stock units
- Both successors are 27-year Stryker veterans aged 49, indicating a deep internal bench and continuity of leadership
- Filing reports no material impact on financial results or guidance; the change is a planned internal succession
- The new COO's M&A mandate may signal an increased focus on acquisitions as a growth lever
03—Questions
Frequently Asked Questions
Who is taking over the key operating roles at Stryker?
Spencer Stiles becomes President and COO, and Dylan Crotty becomes Group President, Orthopaedics, both effective January 1, 2026. Stiles previously led Orthopaedics, and Crotty previously led Instruments.
Does this leadership change affect Stryker's financial outlook?
The filing does not disclose any impact on financial results or guidance. The announcement describes a planned internal succession intended to support continued growth.
How are the executives' compensation packages changing?
Stiles's base salary rises to $1,000,000 with a 100% bonus target, and Crotty's rises to $700,000 with an 85% target. Both are recommended for February 2026 LTIP grants, with target values of about $6M and $3M, respectively.
Why does the new COO's M&A role matter to investors?
Giving the COO responsibility for mergers and acquisitions consolidates strategic deal-making under an operating leader. Investors may watch for an increase in acquisition activity or a shift in capital allocation priorities.
Are the successions linked to any governance or conflict concerns?
The filing states there are no family relationships or undisclosed arrangements tied to the appointments, and neither executive has a related-party transaction requiring disclosure under Item 404(a).
04—Continue